NRF2 induction alone might not be a sufficient therapeutic mechanism in FA, requiring either a combination therapy approach (NRF2 inducer along with another therapeutic mechanism) or a movement to other therapeutic mechanisms. Here, NFE2L2 is linked to Friedreich ataxia.